• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • China Regulations on the Supervision and Administration of Children’s Cosmetics (Draft for soliciting opinions)

China Regulations on the Supervision and Administration of Children’s Cosmetics (Draft for soliciting opinions)

Children's Cosmetics
Monday, 28 June 2021 / Published in Cosmetics, News, NMPA Registration in China

China Regulations on the Supervision and Administration of Children’s Cosmetics (Draft for soliciting opinions)

The NMPA (National Medical Products Administration) issued the Supervision and Administration measures of Children’s Cosmetics (Draft) on June 22, 2021, imposing stricter controls and raising the safety standards on cosmetics for children under the age of 12. The NMPA is currently solicitating for public comments until July 31, 2021.

Highlights

  • Children cosmetics are not allowed to use raw materials intended for freckle-removing, whitening, anti-acne, depilating, deodorant, anti-dandruff, anti-hair loss, hair dyeing, and hair perming.
  • The types of ingredients used in the product formula of cosmetics (such as fragrances, coloring agents, preservatives and surfactants) should be reduced by measuring the physiological needs of children from a scientific point of view
  • Children cosmetics should use raw materials with proven safety record. Otherwise, raw materials that are still being monitored or without significant safety data are not allowed to be used.
  • Children’s cosmetics should be marked with a logo stipulated by the NMPA in a prominent position for easy identification.
  • Cosmetics applicants are encouraged to apply anti-counterfeiting technologies on labelling for consumers to easily identify legally sold products

By James Xu. Contact Cisema if you would like to learn more.

People photo created by prostooleh – www.freepik.com
Tagged under: Children cosmetics, cosmetics

What you can read next

China cosmetic e-commerce operators
China cosmetic e-commerce operators – new measures
NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs
Intense pulsed light therapy device
Intense pulsed light therapy device registration in China – Guidelines amended

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP